Description
Actim ELISA SARS-CoV-2 IgG offers laboratories a reliable and efficient method for mass testing of recent COVID-19 infection providing essential data for disease control measures, pandemic analysis and scientific research in just hours. The test detects recent COVID-19 infection from serum samples by measuring the specific immune reaction against the virus. The highly sensitive and specific test can be used, for example, to obtain critical information about the prevalence of COVID-19 at the population level, or to measure induced immune response during vaccine development.
Request Information
Features
• 96% sensitivity and 98% specificity against RT-PCR
• Highly specific to SARS-CoV-2 in cross-reactivity tests of 16 viruses
• Efficient mass testing for up to 80 samples at once
• Gives quantitative results in less than 2 hours
• Test kit contains all necessary reagents
• Developed and produced in Finland
Request Information
